Jin Li

Director at Mangrove Therapeutics.

Raised on Mangrove Therapeutics filings

$2.5M

of $5M offered across 1 Form D filing

Form D filings: 1
Teammates: 2
Last filing: Jul 31, 2026

Company

Mangrove Therapeutics

Biotech · Sacramento, CA

Therapies targeting an RNA regulator of inflammation

Therapies targeting an RNA regulator of inflammation

Investors: 9
Founded: 2025
Still open: $2.5M

Investors: 9
Sector: Biotech
Founded: 2025
HQ: Sacramento, CA

Mangrove Therapeutics filings

Mangrove Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Jul 31, 2026	Other	$2.5M/ $5M	Form D

OtherFiled Jul 31, 2026Form D
$2.5M/ $5M

Works with

Also named on Mangrove Therapeutics filings

Alexander Simon GreenSecretary, Form D signerForm D signer Benjamin Zhiyi ChenChief Executive Officer (Interim) / President